Cargando…
OR03-6 Further Clinical Evaluation of Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide with Improvements in Glycemic Control Parameters in Multiple Patients with Type 1 Diabetes and Hypoglycemia Unawareness
VC-02 combination product (PEC-Direct) is a clinical-stage regenerative medicine therapy being developed for patients with type 1 diabetes and hypoglycemia unawareness intended to restore homeostatic glycemic control. It is comprised of stem cell-derived pancreatic progenitors (PEC-01) loaded into a...
Autores principales: | Bellin, Melena, Daniels, Mark, Foyt, Howard, Keymeulen, Bart, Kieffer, Timothy, Kroon, Evert, Pipeleers, Daniel, Thompson, David, Wang, Richard, Jaiman, Manasi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624949/ http://dx.doi.org/10.1210/jendso/bvac150.727 |
Ejemplares similares
-
SUN-621 Body Weight and Body Composition in Patients with Chronic Pancreatitis Are Associated with Islet Function After Total Pancreatectomy and Islet Cell Transplantation
por: Harindhanavudhi, Tasma, et al.
Publicado: (2020) -
OR12-05 Blunting Of Sympathetic Activation Of Pancreas As A Cause For Hypoglycemic Unawareness In Hypoglycemia Associated Autonomic Failure
por: Thakkar, Keya, et al.
Publicado: (2023) -
Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device
por: Shapiro, A.M. James, et al.
Publicado: (2021) -
PSAT277 Glucocorticoid Therapy for Management of Hypoglycemia in the context of Non-Islet Cell Tumor-Induced Hypoglycemia
por: Agarwal, Rahul, et al.
Publicado: (2022) -
Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072–1074
por: Hering, Bernhard J., et al.
Publicado: (2017)